Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.89 |
| ▸ | MAPT | P10636 | 3/20 | 0.89 |
| ▸ | MEN1 | O00255 | 2/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.89 |
| ▸ | TSHR | P16473 | 2/20 | 0.89 |
| ▸ | BLM | P54132 | 2/20 | 0.89 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.89 |
| ▸ | MPO | P05164 | 1/20 | 0.89 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.63 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.63 |
| ▸ | LTA4H | P09960 | 1/20 | 0.63 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.63 |
| ▸ | APAF1 | O14727 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | HTR1A | P08908 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Tryptophan SCHEMBL27641165 | 1.00 | KMT2A (0.89) | KMT2AKDM4EMAPTMEN1LMNA | |
| Tryptophan SCHEMBL120930 | 1.00 | KMT2A (0.89) | KMT2AKDM4EMAPTMEN1LMNA | |
| D-Tryptophan SCHEMBL11869971 | 1.00 | KMT2A (0.89) | KMT2AKDM4EMAPTMEN1LMNA | |
| Tryptophan SCHEMBL6046200 | 0.95 | KMT2A (0.80) | KMT2AKDM4EMAPTMEN1LMNA | |
| Tryptophan SCHEMBL23141133 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTMEN1LMNA | |
| Dl-Tryptophan SCHEMBL475349 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTMEN1LMNA | |
| Tryptophan SCHEMBL475350 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTMEN1LMNA | |
| Dl-Tryptophan SCHEMBL19161120 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTMEN1LMNA | |
| Dl-Tryptophan SCHEMBL7327 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTMEN1LMNA | |
| Tryptophan SCHEMBL4732053 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1034 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113514518-B | Preparation method of hydrogen peroxide sensor based on polypeptide-enzyme composite material | 江苏大学 | 2023-05-09 | — | — | CN | claimed |
| CN-115746089-A | Allyl alcohol derivatives and their use in protein modification | 国科大杭州高等研究院 | 2023-03-07 | — | — | CN | claimed |
| CN-113533279-B | Method for detecting enrofloxacin by using fluorescent dipeptide nano microspheres/nucleic acid aptamer | 河北农业大学 | 2022-07-29 | — | — | CN | claimed |
| CN-114182358-A | Anti-tau protein fluorescent polypeptide nanoparticle array, preparation method and application | 西北工业大学 | 2022-03-15 | — | — | CN | claimed |
| CN-111249469-B | Peptide nanoparticle capable of escaping lysosome and preparation method and application thereof | 临沂大学 | 2022-03-08 | — | — | CN | claimed |
| CN-113533279-A | Method for detecting enrofloxacin by using fluorescent dipeptide nano microspheres/nucleic acid aptamer | 河北农业大学 | 2021-10-22 | — | — | CN | claimed |
| CN-113514518-A | Preparation method of hydrogen peroxide sensor based on polypeptide-enzyme composite material | 江苏大学 | 2021-10-19 | — | — | CN | claimed |
| WO-2020204317-A1 | METHOD FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO CHONDROCYTES BY USING OLIGOPEPTIDES | 이화여자대학교 산학협력단 | 2020-10-08 | — | — | WO | claimed |
| CN-111249469-A | Peptide nanoparticle capable of escaping lysosome and preparation method and application thereof | 临沂大学 | 2020-06-09 | — | — | CN | claimed |
| CN-109156824-A | A kind of preoperative special meals drink and the preparation method and application thereof taken of diabetes patient | 广州钮和生物科技有限公司 | 2019-01-08 | — | — | CN | claimed |
| US-20130012457-A1 | BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING | THE UNIVERSITY OF LEEDS | 2013-01-10 | — | — | US | claimed |
| EP-2364991-A1 | A process for the preparation of poly-alfa-glutamic acid and derivatives thereof | Cell Therapeutics, Inc. - Sede Secondaria (IT) | 2011-09-14 | — | — | EP | claimed |
| EP-2027145-A1 | A PROCESS FOR THE PREPARATION OF POLY-ALFA-GLUTAMIC ACID AND DERIVATIVES THEREOF | Cell Therapeutics, Inc. - Sede Secondaria (IT) | 2009-02-25 | — | — | EP | claimed |
| WO-2007144140-A1 | A PROCESS FOR THE PREPARATION OF POLY-ALFA-GLUTAMIC ACID AND DERIVATIVES THEREOF | CELL THERAPEUTICS INC. - SEDE SECONDARIA (IT) | 2007-12-21 | — | — | WO | claimed |
| US-20240043561-A1 | HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-02-08 | — | — | US | disclosed |
| CN-117482145-A | Traditional Chinese medicine extract, preparation method thereof and application thereof in preparation of medicine for treating Alzheimer's disease | 中国科学院长春应用化学研究所 | 2024-02-02 | — | — | CN | disclosed |
| US-11884714-B2 | Cyclic peptide analogs of melanocortin and amanitin and methods of making such | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-01-30 | — | — | US | disclosed |
| CN-1049165-A | The cycloalkyl that N-replaces and the tryptophane-phenylalanine of multi-ring alkyl alpha-substitution-and phenylethylamine derivative | WARNER LAMBERT CO (US) | 1991-02-13 | — | — | CN | disclosed |
| CN-1049165-A | The cycloalkyl that N-replaces and the tryptophane-phenylalanine of multi-ring alkyl alpha-substitution-and phenylethylamine derivative | WARNER LAMBERT CO (US) | 1991-02-13 | — | — | CN | disclosed |
| CN-1049165-A | The cycloalkyl that N-replaces and the tryptophane-phenylalanine of multi-ring alkyl alpha-substitution-and phenylethylamine derivative | WARNER LAMBERT CO (US) | 1991-02-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11884714-B2 | Cyclic peptide analogs of melanocortin and amanitin and methods of making such | MC3R, MC5R, MC4R | KMT2A 3454/4885KDM4E 3918/4885MAPT 1427/4885 |
| US-20240043561-A1 | HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF | CD47, FCGR2A, FCGR3B | KMT2A 496/4885KDM4E 3096/4885MAPT 2344/4885 |
| US-20130012457-A1 | BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING | IAPP, TAGLN2, KRT18 | KMT2A 4472/4885KDM4E 4717/4885MAPT 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.